Ushbu ish iqtibos qilgan ishlar
361 ta ish
Ish: Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Maqola20207 iqtibosABIUnveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Sharh maqolaOchiq kirish20256 iqtibosABIRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi, Matthew H. Larson, Luke A. Gilbert +4
MaqolaOchiq kirish20135 iqtibosABIDelivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney +1
Sharh maqolaOchiq kirish20185 iqtibosABICRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp, Kathrin Schumann, Kole T. Roybal +4
MaqolaOchiq kirish20174 iqtibosABICRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38
MaqolaOchiq kirish20203 iqtibosABIEpigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy
Rajkumar Prabhakaran, Rajkumar Thamarai, Sivabalan Sivasamy +6
Sharh maqolaOchiq kirish20243 iqtibosABINanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation
Ashok Kumar Bishoyi, Sina Nouri, Ahmed Hussen +3
Sharh maqolaOchiq kirish20253 iqtibosABICAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3
Sharh maqola20223 iqtibosABIEpigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Yanlin Wu, Zhengjun Lin, Changchun Li +7
Sharh maqola20233 iqtibosABIHigh-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu, Jennifer A Foden, Cyd Khayter +4
MaqolaOchiq kirish20132 iqtibosABIProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Nicole M. Gaudelli, Alexis C. Komor, Holly A. Rees +4
MaqolaOchiq kirish20172 iqtibosABITRAPT: a multi-stage fused deep learning framework for predicting transcriptional regulators based on large-scale epigenomic data
Guorui Zhang, Chao Song, Mingxue Yin +6
MaqolaOchiq kirish20252 iqtibosABIDeletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech +17
MaqolaOchiq kirish20232 iqtibosABI“Galectin-9: A double-edged sword in Acute Myeloid Leukemia”
Omolbanin Sargazi-Aval, Ali Ahmadi, Ali Jihad Hemid Al-Athari +5
Sharh maqolaOchiq kirish20252 iqtibosABIInsights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies
Sara Zehtabcheh, Hamed Soleimani Samarkhazan, Marjan Asadi +3
Sharh maqolaOchiq kirish20252 iqtibosABI